Navigation Links
Journal of Managed Care Pharmacy recognizes Prime Therapeutics with two 2012 JMCP Award for Excellence Honorable Mentions
Date:5/7/2013

me. "These study results suggest that health insurers and PBMs should work to ensure that claims information is complete on pharmacies with membership drug discounts."

Authors of the study were: Alexandra Tungol , PharmD; Catherine I. Starner , PharmD, BCPS, CGP; Brent W. Gunderson , PharmD; Jeremy A. Schafer , PharmD, MBA; Yang Qiu , MS; and Gleason.

The study can be found at: http://www.amcp.org/WorkArea/DownloadAsset.aspx?id=15873

Rosiglitazone Prior Authorization Safety Policy

In the second study, Prime collaborated with Florida Blue to evaluate drug use among 1.4 million commercially insured members who were exposed to a rosiglitazone PA program beginning January 1, 2009. These members were compared with a group of approximately 2 million commercially insured members who did not have this safety PA intervention.

The study found that the rosiglitazone PA was successful in significantly reducing concurrent use of nitrates and insulin among health plan members with type 2 diabetes.

"Previous studies have found that prior authorization programs reduce drug utilization and costs, but it has been unclear whether patients were impacted positively or negatively," said Gleason. "Our study is unique in that the findings support the use of a PA to promote safe prescribing as evidenced by the potential cardiovascular event risk avoidance for patients."

The authors were: Catherine I. Starner , PharmD, BCPS,CGP; Beckie Fenrick , PharmD (formerly with Florida Blue ); Peter Wickersham , MS, MBA; and Patrick P. Gleason , PharmD, BCPS
'/>"/>

SOURCE Prime Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Elsevier Selected as New Publisher of The American Journal of Geriatric Psychiatry
2. Telik Announces the Publication of Two Reports in the Journal Of Hematology & Oncology Describing the Results of a Clinical Study of Telintra® in Combination With Revlimid® and a Genomic Study Designed to Identify Genes That Predict Response to Teli
3. Study Results of Novocures NovoTTF™ Pivotal Phase 3 Trial Published in European Journal of Cancer
4. Cardiac Dimensions® Announces Publication of TITAN Clinical Trial Data in European Journal of Heart Failure
5. NAMS Journal Menopause Reflects on the WHI 10 Years Later
6. Elsevier and the Society for Vascular Surgery Announce Forthcoming Launch of Journal of Vascular Surgery: Venous and Lymphatic Disorders
7. Call for Entries: International Bureau for Epilepsy and UCB launch the 2012 Excellence in Epilepsy Journalism Award to recognize exceptional reporting on epilepsy
8. MedVantx MedStart™ Solves Problem Highlighted in Study Published in Journal of the American Board of Family Medicine - Expired Medications in Physician Office Sample Closets
9. Obesity journal publishes new study on lorcaserin, a weight-loss medication recommended for approval by FDA advisory panel
10. Lexicon Announces Publication of Results of Two Studies of LX4211 in Patients with Type 2 Diabetes in the Journal Clinical Pharmacology & Therapeutics
11. Medical Device Daily Wins Prestigious SIPA Award for Outstanding Business Journalism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... SAN DIEGO, Aug. 1, 2014 Arena ... provided a corporate update and reported financial results ... "We have continued to see ... including a 43% quarter-over-quarter increase in estimated total ... the 10,000 mark," said Jack Lief, Arena,s President ...
(Date:7/31/2014)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ; Sorrento) ... Chief Business Officer and Executive Vice President. Mr. Singh died ... "Sorrento is deeply saddened and shocked by the ... go to Amar,s family and friends," said Henry Ji ... Mr. Singh joined Sorrento in January 2014 from Synta ...
(Date:7/31/2014)... July 31, 2014 Tandem Diabetes Care®, Inc. (NASDAQ: ... of the t:slim® Insulin Pump, today reported its financial results ... In comparing the second quarter of 2014 to the same ... $10.3 million from $5.5 million , t:slim Pump shipments ... In comparing six months ended June 30, 2014 to ...
Breaking Medicine Technology:Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 2Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 3Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 4Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 5Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 6Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 7Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 8Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 9Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 10Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 11Sorrento Announces the Unexpected Death of its Chief Business Officer 2Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 2Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 3Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 4Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 5Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 6
(Date:8/1/2014)... New York, New York (PRWEB) August 01, 2014 ... ( http://www.gynecaremorcellatorlawsuit.com/ ) on behalf of women who allegedly ... use of power morcellators in gynecological surgeries, Bernstein Liebhard ... decision to withdraw a number of power morcellators marketed ... to a report from The New York Times, some ...
(Date:8/1/2014)... and the benefits of a cancer diagnosis may improve ... a study conducted by a researcher at the University ... an expressive writing intervention is the writing instruction. Otherwise, ... events. Writing a journal can be therapeutic, but oftentimes ... it,s effective or not," said Qian Lu, assistant professor ...
(Date:8/1/2014)... DELRAY BEACH, FL (PRWEB) August 01, 2014 ... hosted the 2014 California NextGen User Symposium in San ... event was held at the JW Marriott Union Square ... to help practices get up to speed with ACA ... said earlier this month. The symposium provides attendees guidance ...
(Date:8/1/2014)... August 01, 2014 According to ... by Geography (Asia-Pacific, North America, Europe, & ROW), ... by Fuel Type (Gasoline & Diesel), by After-Treatment ... - Trends & Forecasts to 2019", defines and ... an analysis of major countries in all the ...
(Date:8/1/2014)... (BRONX, NY) Scientists at Albert Einstein ... that bacteria that aid in digestion help keep the ... journal Immunity , could yield new therapies for ... other disorders. , The research involved the intestinal microbiome, ... these microorganisms in promoting or preventing disease is a ...
Breaking Medicine News(10 mins):Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 4Health News:Expressive writing may help breast cancer survivors 2Health News:Expressive writing may help breast cancer survivors 3Health News:Quirk Healthcare Foundation Hosts Fifth Annual California NextGen User Symposium and Launches First Annual Florida NextGen User Symposium 2Health News:Automotive Exhaust Systems Market Will Be $33,379.7 Million by 2019 – New Report by MarketsandMarkets 2Health News:Automotive Exhaust Systems Market Will Be $33,379.7 Million by 2019 – New Report by MarketsandMarkets 3Health News:Automotive Exhaust Systems Market Will Be $33,379.7 Million by 2019 – New Report by MarketsandMarkets 4Health News:'Normal' bacteria vital for keeping intestinal lining intact 2
... Study found higher levels of staph, E. coli in ... News) -- Could common bacterial infections cause some cases of sudden ... of a study in this week,s issue of The Lancet ... levels of Staphylococcus aureus and Escherichia coli ...
... 29 Alexza,Pharmaceuticals, Inc. (Nasdaq: ALXA ... joined the company as Vice President, International ... the development and,execution of clinical and regulatory ... candidates. Dr. Clarke was most recently,Vice President, ...
... MATK ) announced today that it will be ... Medical Technology,Conference in New York. The conference is being ... Palace Hotel. Peter L. Buzy, CFO is scheduled to ... Time., A live audio webcast of Martek,s presentation ...
... Ltd.,(Nasdaq: EMITF ) ("EI" or the "Company") today ... Loss for the first quarter of 2008 amounted to ... of NIS 27.3 million,(approximately US$ 7.7 million) is attributable ... NIS 23.8 million (approximately US$ 6.7,million) is attributable to ...
... the continued presence of a doula an experienced non-medical ... beneficial effects for middle- and upper-class women in childbirth, even ... with them, according to a new study in the journal ... of 420 pregnant women in their third trimester were randomized ...
... A critical enzyme used to prepare a powerful ... better target the cells the natural product attacks, according ... the Journal of Biological Chemistry. , Building on their ... Boston College and the University of Wisconsin, Madison discovered ...
Cached Medicine News:Health News:Bacterial Infection May Boost SIDS Risk 2Health News:Bacterial Infection May Boost SIDS Risk 3Health News:Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations 2Health News:Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations 3Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 2Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 3Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 4Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 5Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 6Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 7Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 8Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 9Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 10Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 11Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 12Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 13Health News:Enzyme may hold key to improved targeting of cancer-fighting drugs 2
... bring a new standard in the field of ... Labs. Made of medical grade silicone, these durable ... a high level of flexibility while maintaining correct ... available in varying stiffnesses. Lengths are determined by ...
... primary objective of the BioPro Toe implant ... will relieve pain and restore motion while ... undisturbed. The procedure used to implant the ... resection. , ,The design for the great ...
Ad-Techs Spinal Electrodes are intended for intraoperative monitoring of Evoked Potentials (EPs) of the descending pathway during spinal surgery. They are offered with 2 or 3 platinum contacts....
... of Ad-Techs products, our Sphenoidal Electrodes are manufactured ... available in stainless steel or platinum and feature ... (70 mm) long, 21 gauge (0.83 mm) introducing ... as kits or sets. You can also choose ...
Medicine Products: